Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like Agenda – PRAC draft agenda of meeting 7-10 February 2022 Agenda – PDCO agenda of the 22-25 March 2022 meeting Agenda – Third European Medicines Agency and Association of the European Self-Medication Industry (AESGP) annual bilateral meeting
Agenda – Third European Medicines Agency and Association of the European Self-Medication Industry (AESGP) annual bilateral meeting
